
Sign up to save your podcasts
Or


Join Dr. Karmy for an interview with Dr. Warren Goldstein, a neurologist with extensive experience in headache management.
In this episode, we will have an in-depth discussion about a new class of migraine medications that block CGRP neuropeptides. Are the risks worth the benefits? What about insurance coverage?
Should you try this new class of medications? Find out.
If you have any questions for Dr. Karmy, feel free to email us at [email protected].
Follow our social media:
Instagram
https://www.instagram.com/karmychronicpain?igsh=cHZycXdzeGhqN2Zn
Facebook
https://www.facebook.com/profile.php?id=61550237320641&mibextid=dGKdO6
Send us a text with your thoughts on this episode!
Learn more about pain management treatments offered at our clinic: https://karmyclinic.com/
By Dr Grigory KarmyJoin Dr. Karmy for an interview with Dr. Warren Goldstein, a neurologist with extensive experience in headache management.
In this episode, we will have an in-depth discussion about a new class of migraine medications that block CGRP neuropeptides. Are the risks worth the benefits? What about insurance coverage?
Should you try this new class of medications? Find out.
If you have any questions for Dr. Karmy, feel free to email us at [email protected].
Follow our social media:
Instagram
https://www.instagram.com/karmychronicpain?igsh=cHZycXdzeGhqN2Zn
Facebook
https://www.facebook.com/profile.php?id=61550237320641&mibextid=dGKdO6
Send us a text with your thoughts on this episode!
Learn more about pain management treatments offered at our clinic: https://karmyclinic.com/